Valuation: PROCEPT BioRobotics Corporation

Market Cap 1.05B 909M 849M 779M 1.47B 99.72B 1.49B 10.01B 3.92B 49.73B 3.93B 3.84B 164B P/E 2026 *
-12x
P/E 2027 * -20.8x
Enterprise Value 928M 806M 753M 691M 1.3B 88.43B 1.33B 8.88B 3.48B 44.1B 3.48B 3.41B 145B EV / Sales 2026 *
2.33x
EV / Sales 2027 * 1.87x
Free-Float
96.83%
Yield 2026 *
-
Yield 2027 * -
1 day-1.29%
1 week+3.90%
Current month-1.29%
1 month-12.60%
3 months-25.38%
6 months-37.03%
Current year-41.58%
1 week 17.44
Extreme 17.44
19.17
1 month 16.66
Extreme 16.665
21.88
Current year 16.66
Extreme 16.665
35.4
1 year 16.66
Extreme 16.665
49.9
3 years 16.66
Extreme 16.665
103.81
5 years 15.38
Extreme 15.38
103.81
10 years 15.38
Extreme 15.38
103.81
Manager TitleAgeSince
Chief Executive Officer 60 2025-09-01
Director of Finance/CFO 48 2018-09-30
Chief Operating Officer 56 2026-02-28
Director TitleAgeSince
Chairman 74 2021-02-28
Director/Board Member 48 2015-05-31
Director/Board Member 50 2020-11-30
Date Insider Type Main position Quantity % Market Cap.
6/8/26 Sell

Chief Financial Officer

-357 0.0006%
6/8/26 Sell

General Counsel

-285 0.0005%
3/5/26 Free

Chief Executive Officer

231,436 0.4142%
Change 5-day change 1-year change 3-year change Capi.($)
-1.29%+3.90%-63.21%-47.81% 1.05B
+1.34%+2.52%-15.85%-0.39% 185B
+1.51%+2.92%-2.98%+2.59% 111B
-0.95%-0.89%+6.94%+61.15% 60B
+2.63%+9.46%+43.51%+59.34% 53.9B
+2.77%+7.10%-3.49%-36.65% 46.9B
+3.03%+1.94% - - 34.22B
+4.63%+19.00%+10.13%-28.48% 32.95B
+2.05%+5.04%+45.42%-5.89% 24.49B
+1.86%+6.52%+2.54%+3.17% 22.67B
Average +1.51%+5.04%+2.56%+0.78% 57.25B
Weighted average by Cap. +1.08%+3.77%+1.43%+7.99%

Financials

2026 *2027 *
Net sales 397M 345M 322M 296M 558M 37.88B 568M 3.8B 1.49B 18.89B 1.49B 1.46B 62.31B 490M 426M 398M 365M 688M 46.72B 700M 4.69B 1.84B 23.3B 1.84B 1.8B 76.84B
Net income -86.46M -75.14M -70.15M -64.4M -121M -8.24B -124M -827M -324M -4.11B -325M -318M -13.55B -47.62M -41.39M -38.64M -35.47M -66.88M -4.54B -68.05M -456M -178M -2.26B -179M -175M -7.47B
Net Debt -118M -103M -96.09M -88.22M -166M -11.29B -169M -1.13B -444M -5.63B -445M -435M -18.57B -131M -114M -107M -97.95M -185M -12.53B -188M -1.26B -493M -6.25B -494M -483M -20.62B
Logo PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are advanced, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). It designed Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that is independent of prostate size and shape and delivers resection independent of surgeon experience. It manufactures the robotic systems, the single-use disposable handpiece, integrated scope and other accessories at its facility in San Jose, California. Each robotic system is shipped to its customers with a third-party manufactured ultrasound system and probe.
Employees
888
Date Price Change Volume
26-08-04 US$17.92 -2.50% 423,959
26-08-03 US$18.38 -1.29% 2,900,588
26-07-31 US$18.62 +3.44% 1,179,280
26-07-30 US$18.00 +0.67% 1,211,145
26-07-29 US$17.88 -1.11% 991,910
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
18.38USD
Average target price
28.45USD
Spread / Average Target
+54.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PRCT Stock